DVA
DaVita Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
DaVita Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients. Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients. Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
No other changes.
Last report5 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
Annual filing, covered
10-K parsed · Feb 11 '26
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Annual filing, covered
10-K parsed · Feb 11 '26
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
No thesis.
Same SIC code · 6
Same SEC industry code: Sotera Health Co, Progyny, Inc., agilon health, inc. and 3 more; of DaVita Inc.'s 6 closest co-movers, none share that code.
Same SIC code · 6
Same SEC industry code: Sotera Health Co, Progyny, Inc., agilon health, inc. and 3 more; of DaVita Inc.'s 6 closest co-movers, none share that code.
−3.01%
vs ±10.1% implied · ×0.30
shaded = implied · ▲▼ = realized
DaVita Inc.
181.02
−1.15 · −0.63%
post 192.63 +6.41%
Tall tick = annual report · Source: EDGAR
| Manager | Value | % base | |
|---|---|---|---|
| Berkshire Hathaway | $6.4B | 47.19% | −4.05% |
| BlackRockindex-like | $547.5M | 4.02% | −11.05% |
| Vanguardindex-like | $467.5M | 3.43% | −3.61% |
| Morgan Stanley | $356.3M | 2.62% | −3.86% |
| Vanguard Portfolioindex-like | $306.6M | 2.25% | −6.87% |
| Manager | Value | % base | |
|---|---|---|---|
| Berkshire Hathaway | $6.4B | 47.19% | −4.05% |
| BlackRockindex-like | $547.5M | 4.02% | −11.05% |
| Vanguardindex-like | $467.5M | 3.43% | −3.61% |
| Morgan Stanley | $356.3M | 2.62% | −3.86% |
| Vanguard Portfolioindex-like | $306.6M | 2.25% | −6.87% |
Bull2
Bear1
Expected move
Inputs8Q avg ±11.4%·×0.60·cheap
straddle ±14.5%
spot 182.17exp Feb 19ATM strike 180ATM straddle 31.15IV 40%